CMS certification 100168
Boca Raton Regional Hospital
800 Meadows Rd, Boca Raton, FL 33486
Boca Raton Regional Hospital has a CMS overall rating of 2 out of 5 stars. 65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. Emergency patients spend a median of 3 h in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,150 completed surveys, 27% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | FL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 345 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h | 2 h 36 min | 2 h 42 min |
| Left before being seen Lower is better · 54,639 patients | 2% | 1% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 13 patients | 92% | 73% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 212 patients | 75% | 73% | 65% |
How Boca Raton Regional Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Boca Raton Regional HospitalThis hospital | 2/5 | 65% | 3 h | 5 better 1 worse |
| West Boca Medical CenterSame city | 3/5 | 50% | 2 h 17 min | 1 better |
| Delray Medical CenterSame county · Delray Beach | 1/5 | 44% | 2 h 24 min | 6 better 4 worse |
| HCA Florida Palms West HospitalSame county · Loxahatchee | 2/5 | 64% | 2 h 5 min | 2 better 4 worse |
| HCA Florida Jfk HospitalSame county · Atlantis | 2/5 | 58% | 2 h 20 min | 3 better 3 worse |
| Jupiter Medical CenterSame county · Jupiter | 4/5 | 80% | 3 h 6 min | 4 better 3 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Boca Raton.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,628 cases | Too few cases | 3.5% | 3.9% |
| Heart attack 299 cases | Too few cases | 12.2% | 11.9% |
| Heart failure 1,018 cases | Too few cases | 11% | 11.1% |
| Pneumonia 1,413 cases | Too few cases | 14.3% | 15.2% |
| Stroke 455 cases | Too few cases | 12.8% | 11.9% |
| COPD 226 cases | Too few cases | 7.2% | 8.6% |
| Heart bypass surgery (CABG) 96 cases | Too few cases | 3.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.18 likely 0.93 – 1.44 | 1 |
| After hip or knee replacement 99 cases | Too few cases | 4.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 159 cases | Better | 125.65 per 1,000 likely 86.84 per 1,000 – 164.46 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 13,101 cases | No different | 0.77 per 1,000 likely 0.25 per 1,000 – 1.29 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 14,711 cases | No different | 0.1 per 1,000 likely 0 per 1,000 – 0.27 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 15,298 cases | No different | 0.19 per 1,000 likely 0.02 per 1,000 – 0.36 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,486 cases | No different | 1.85 per 1,000 likely 0.62 per 1,000 – 3.09 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,527 cases | No different | 2.86 per 1,000 likely 1.4 per 1,000 – 4.32 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,456 cases | No different | 11.92 per 1,000 likely 6.68 per 1,000 – 17.17 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,660 cases | No different | 5.04 per 1,000 likely 3.38 per 1,000 – 6.69 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,436 cases | No different | 5.62 per 1,000 likely 2.5 per 1,000 – 8.73 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 941 cases | No different | 1.7 per 1,000 likely 0.33 per 1,000 – 3.08 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,191 cases | No different | 0.71 per 1,000 likely 0 per 1,000 – 1.51 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.36 likely 0.09 – 0.98 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.26 likely 0.08 – 0.62 | 1 |
| Surgical site infections after colon surgery | Better | 0.14 likely 0.01 – 0.7 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.16 likely 0.3 – 3.15 | 1 |
| MRSA bloodstream infections | No different | 0.56 likely 0.18 – 1.35 | 1 |
| C. diff intestinal infections | Better | 0.18 likely 0.08 – 0.34 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 276 cases | Too few cases | 13.9% | 14.4% |
| Readmitted after heart failure 1,136 cases | Too few cases | 20.4% | 21.3% |
| Readmitted after pneumonia 1,426 cases | Too few cases | 16.1% | 17.3% |
| Readmitted after COPD 224 cases | Too few cases | 19.4% | 20% |
| Readmitted after heart bypass surgery 92 cases | Too few cases | 13.8% | 11% |
| Readmitted after hip or knee replacement 95 cases | Too few cases | 6.2% | 5.8% |
| Days back in hospital after a heart attack 285 cases | Too few cases | 27.9 days per 100 | — |
| Days back in hospital after heart failure 1,137 cases | Too few cases | -0.6 days per 100 | — |
| Days back in hospital after pneumonia 1,481 cases | Too few cases | -6.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 645 cases | No different | 13.2 per 1,000 likely 10 per 1,000 – 17.1 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,123 cases | No different | 10.2 per 100 likely 8.8 per 100 – 11.8 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,123 cases | Better | 2.7 per 100 likely 2.1 per 100 – 3.5 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,364 cases | Better | 0.8 likely 0.7 – 1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
203 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 138 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Diagnostic Radiology | 31 |
| Anesthesiologist Assistant | 25 |
| Internal Medicine | 20 |
| Anesthesiology | 11 |
| Anatomic Pathology & Clinical Pathology | 10 |
| Neurology | 10 |
| Family | 9 |
| Physician Assistant | 9 |
| Surgery | 9 |
| Emergency Medical Services | 8 |
| Neurological Surgery | 8 |
| Emergency Medicine | 6 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.2M
- 2020 $1.3M
- 2021 $1.3M
- 2022 $788,797
- 2023 $694,049
- 2024 $296,192
- 2025 $224,800
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Royalties and licensing fees | $120,000 | 1 |
| Space rental and facility fees | $22,500 | 7 |
| Grants | $11,000 | 4 |
| Debt forgiveness | $7,919 | 5 |
| Gifts | $5,500 | 1 |
| Consulting fees | $3,000 | 1 |
| Speaking, teaching and other services | $3,000 | 1 |
| Food and beverage | $42 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Volpara Health, Inc. | $123,000 | 2 |
| Janssen Research & Development, LLC | $20,196 | 6 |
| Cook Research Incorporated | $18,675 | 4 |
| Merck Sharp & Dohme LLC | $8,882 | 3 |
| Biotronik INC. | $7,395 | 2 |
| Alexion Pharmaceuticals, Inc. | $5,500 | 1 |
| Argenx US, INC. | $5,500 | 1 |
| Pacira Pharmaceuticals Incorporated | $5,000 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Study of TAR200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle invasive Bladder Cancer MIBC of the … Janssen Research & Development, LLC | $20,196 |
| US Aortic Research Consortium (US ARC) Cook Research Incorporated | $18,675 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab MK-3475 as Monotherapy in the Adjuvant Treatment of Renal Cel… Merck Sharp & Dohme LLC | $5,546 |
| PH III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN COPD Genentech, Inc. | $3,632 |
| A STUDY OF ENFORTUMAB VEDOTIN ASG22CE AS MONOTHERAPY OR IN COMBINATION WITH OTHER ANTICANCER THERAPIES FOR THE TREATMENT OF UROTHELIAL CANCER PFIZER INC. | $1,985 |
| PH III open label study atezo vs BSC following adjuvant chemo in stage IB IIIA NSCLC Genentech, Inc. | $964 |
| A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF OLOMORASIB IN COMBINATION WITH STANDARD OF CARE I… Eli Lilly and Company | $478 |
| A Randomized, Double-Blind, Phase III Study of Carboplatin-Paclitaxel,Nab-Paclitaxel Chemotherapy with or without Pembrolizumab MK-3475 in First Line… Merck Sharp & Dohme LLC | $337 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Boca Raton Regional Hospital
Is Boca Raton Regional Hospital a good hospital?
Boca Raton Regional Hospital has a CMS overall rating of 2 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Boca Raton Regional Hospital?
65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,150 completed HCAHPS surveys.
How long is the wait in the Boca Raton Regional Hospital emergency room?
Emergency patients spend a median of 3 h in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Boca Raton Regional Hospital receive money from drug and device companies?
Drug and device makers reported $224,800 in payments to Boca Raton Regional Hospital for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.